Laura C. Speltz, MD

An 8 year old boy is transferred from a community hospital to a tertiary care center after experiencing a first time generalized seizure. He has an extensive past medical history including a genetically confirmed diagnosis of neurofibromatosis type 1, autism spectrum disorder, strabismus repair, and an optic glioma on magnetic resonance imaging (MRI) of the brain.

The child was born at term via vaginal delivery without complications. His early gross motor milestones were delayed and he started walking at 18 months of age. He was diagnosed with hypotonia and enrolled in physical therapy. Subsequently, he was referred to a neurocutaneous clinic due to the presence of café au lait spots and inguinal freckling. A diagnosis of neurofibromatosis type 1 was confirmed with genetic testing. Initial brain MRI was within normal limits. At 3 years of age he was seen for a neuropsychological evaluation and diagnosed with an autism spectrum disorder.

At 5 years of age, he developed new episodes of headaches and emesis. His mother reported that he would develop a red rash on his chest and turn very pale. He would complain of brief headaches lasting less than 5 minutes and report an odd taste in his mouth. He would proceed to retch and vomit for several minutes; occasionally the symptoms could wax and wane over the course of several hours. With some of these events he would have urinary incontinence. His mother also reported secondary urinary incontinence and enuresis unrelated to the episodes of recurrent emesis. He was referred for a gastrointestinal evaluation and had a normal upper endoscopy. He was seen by urology for his incontinence but no cause was found.

He continued to have episodes of emesis and headache on a nearly monthly basis. He was seen by a neurologist and repeat head imaging was obtained. He had developed a right optic nerve glioma as well as a non-enhancing FLAIR hyperintensity in his left cerebral peduncle consistent with a neurofibromatosis-associated bright object. He had a normal routine EEG. He was diagnosed with cyclic vomiting syndrome and was started on cyproheptadine for migraine prophylaxis. He was prescribed sumatriptan as needed without significant improvement.

The events in question escalated in frequency and severity over the course of several years. He was seen repeatedly in the local emergency room and admitted for dehydration. During one such hospitalization, he was prescribed lorazepam 1 mg every 8 hours as needed for agitation. This treatment appeared to improve his gastrointestinal symptoms by shortening the duration of the episodes of retching and emesis. His mother began to treat him with this benzodiazepine therapy at home as needed for the recurrence of his symptoms.  

During a subsequent hospitalization, the patient was retching and had experienced repeated bouts of emesis for approximately 1 hour when he abruptly developed clinical seizure activity associated with head deviation to the left, stiffening of his extremities, lip smacking, and urinary incontinence. This clinical seizure activity lasted 10 minutes before resolving with administration of lorazepam intravenously. He was sleepy and confused thereafter. His electrolytes and glucose were within normal limits.

The patient was loaded with intravenous levetiracetam and transferred to a tertiary care center for further evaluation. His routine EEG was, again, normal. An MRI revealed mild subcortical and cortical edema in the bilateral frontal and parietal lobes which was attributed to his prolonged seizure activity. He was discharged home on levetiracetam prophylaxis. After discharge he had no additional episodes of vomiting and/or headache for 2 years. His secondary urinary incontinence also resolved.

In the fall of 2019, he developed recurrent episodes of daytime and night time urinary incontinence. He reported no memories of the events. His levetiracetam dose was increased and these episodes resolved. Subsequently, he had an episode at school concerning for breakthrough seizure activity. After gym, his school Registered Nurse called his mother because he was very pale and curled up in a fetal position. He was incoherent and speaking gibberish, but wasn't able to respond to his mother. When he tried to respond, his speech was very slow. He was retching, but had not yet vomited. He developed his typical vascular rash over his chest as well. His mother came to the school and administered 7.5 mg of buccal diazepam. Thereafter, he threw up but did not return to his baseline. The constellation of symptoms above persisted, so his mother took him to the Emergency Room where he was given a loading dose of levetiracetam with symptom resolution. He was admitted for a video EEG that was normal for 48 hours. His levetiracetam dose was increased and his symptoms again have resolved for the past month.

Epilepsy in neurofibromatosis is relatively common. A recent analysis found that 26 of 184 patients with neurofibromatosis were also diagnosed with epilepsy; of this group 17 (65%) had localization related epilepsy.

Migraines and migraine variants are also common in the pediatric population and can be challenging to differentiate from epilepsy due to the similarities in symptomatology and the frequent comorbidity of the 2 conditions.

Taking a detailed history and monitoring for response to initial therapies can help narrow the differential diagnosis. A normal EEG does not exclude the possibility of an underlying seizure disorder. Clinicians should have an increased degree of suspicion for seizures in children with risk factors for epilepsy including neurocutaneous syndromes and autism spectrum disorders.

1. Pecoraro A, Arehart E, Gallentine W, et al. Epilepsy in neurofibromatosis type 1. 

. 2017;73:137-141. doi: 10.1016/j.yebeh.2017.05.011.

2. Oakley CB, Kossoff EH. Migraine and epilepsy in the pediatric population. 

 2014;18(3):402. doi: 10.1007/s11916-013-0402-3.

Articles

An 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.

Cyclic Vomiting, Incontinence in a Young Boy

A full-term newborn presented with new onset paroxysmal episodes concerning for seizure activity. The baby girl was the product of a healthy pregnancy to a 31-year-old gravida 2 para 1 mother. The mother of the infant reported a history of chronic hypertension preceding pregnancy, but was otherwise healthy. The baby girl was born at 37 and 5/7 weeks gestational age via cesarean section; this was a planned repeat cesarean section and there were no concerns for prenatal fetal distress.

The baby was transverse within the uterus, but the delivery was uncomplicated and the infant cried immediately and took her first breath spontaneously. Poor color was observed 4 minutes after birth and the infant was noted to be saturating in the 50s. She was given blow by oxygen and her saturations improved to the 90s along with her color. The infant was noted to have deep subcostal retractions with intermittent nasal flaring. CPAP was subsequently initiated at 8 minutes of life with 50% FiO2 when her saturations dipped to the 80s. After 5 minutes, CPAP was weaned and she was stable on room air, although her mild subcostal retractions and intermittent nasal flaring were persistent. Her apgars were recorded as 8 and 8 at 5 and 10 minutes of life. respectively.

The infant’s birth weight was recorded as 3200 g (36

 percentile), and her head circumference was 37.5 cm (95

The remainder of her stay in the newborn nursery was unremarkable and she was discharged home on day 3 of life. Her discharge exam was notable for a large anterior fontanelle with a slightly wide metopic suture and bilateral preauricular skin tags. Her neurological exam at discharge described normal and symmetric muscle tone, strength, and deep tendon reflexes.

On day 7 of life, she presented to the emergency room with new onset episodes of lateral gaze deviation with 4-extremity stiffening. She had a witnessed episode of left lateral gaze deviation in triage with associated body tensing. There was no antecedent history of fever, poor feeding, increased sleeping, trauma, or signs of illness. Her stat glucose was 83, and her stat electrolyte panel was normal.

In the emergency room, her mental status was described as alert and age appropriate. Her anterior fontanelle was soft and open. Her neck was supple. There were no signs of trauma. HEENT, cardiovascular, respiratory, and abdominal examinations were normal. Her neurological exam was described as “awake and crying with stimulation.”

She was initially loaded with 20 mg/kg of intravenous phenobarbital with resolution of seizure activity. The infant was taken for a stat head CT which was normal for age without evidence of acute pathology. She underwent a lumbar puncture and was started on prophylactic ampicillin, cefotaxime, and acyclovir.

Platelets, 451 (differential: 26% neutrophils, 51% lymphocytes)

Comprehensive metabolic panel, within normal limits including a sodium of 140, glucose 81, and calcium 10

Urinalysis, unremarkable except for trace blood

CSF studies: glucose, 44; protein, 100; white blood cell count, 7 (differential, 43% lymphocytes, 57% monocytes); and red blood cell count 37

HSV PCR, as well as blood, urine, and CSF cultures were all sent from the emergency room

The infant was admitted to the neonatal ICU and video EEG monitoring was initiated. Her initial neurological exam in the NICU was significant for the baby being “drowsy” and diffusely mildly hypotonic. Otherwise, her physical exam and neurological exam were unchanged. Her initial EEG following admission was notable for periods of discontinuity lasting up to 5 seconds or longer as well as frequent multifocal sharp waves that were excessive for the infant’s gestational age. Overall, the EEG interpreted as concerning for a moderate, diffuse encephalopathy.

The morning after admission, the patient’s EEG revealed a total of 10 subclinical seizures between 8 AM and 10:40 AM. These seizures all emerged from the patient’s right temporal lobe and occipital cortical region and lasted between 50 to 120 seconds. No clinical correlate was appreciated on video EEG monitoring. The nursing team raised concerns about episodes of eye deviation, but these did not have an electrographic correlate. Subsequently she was loaded with an additional 10 mg/kg of phenobarbital with resolution of the seizure activity. She was started on phenobarbital maintenance at 4 mg/kg/QHS.

Her initial neurological exam by the consulting neurology team was notable for an awake infant who would intermittently cry. Her head circumference was 36.5 cm (89

 percentile). Her anterior fontanelle was soft, and her pupils were 3 mm and reactive bilaterally to penlight interrogation. She did not fix visually or follow faces. Her face was symmetric, her tongue was midline, and her palate elevated symmetrically with cry. She had a disorganized suck reflex. Muscle tone, bulk, and strength were felt to be age appropriate. Reflexes were 2/2 throughout and symmetric. No clonus was noted at her ankles. Her Moro reflexes as well as palmar and plantar grasp reflexes were intact and symmetric.

Her brain MRI on day 8 of life was notable for slightly delayed myelination for gestational age. The radiologist noted nonspecific T2 hyperintensity in the white matter diffusely and a borderline increased T1 signal in the basal ganglia and thalami. There was no diffusion restriction to suggest acute hypoxic ischemic injuries, but sequelae of subacute hypoxic ischemic injury could not be excluded.

The infant was reconnected to video EEG after her MRI was performed and her electrographic seizure activity recurred approximately 15 hours after it had ceased with second phenobarbital bolus. Focal seizures were noted independently from the bitemporal regions. Her bedside team was readily able to identify this seizure activity as she was having desaturations with the seizure events or her breathing would change distinctly and she would make a “gulping” noise. She was loaded with levetiracetam 50 mg/kg intravenously without resolution of her seizure activity.

Additional laboratory evaluation on day 8 of life included serum ammonia, lactate, pyruvate, amino acids, acylcarnitine, and urine organic acids. The neurology team verified that her newborn screen had returned within normal limits. She also underwent a second lumbar puncture for metabolic screening.  Simultaneous CSF and serum glucose samples was sent to rule out glut-1 deficency. The ratio of serum and CSF glucose fell within normal limits. Her CSF was also sent out for lactate, pyruvate, CSF amino acids, CSF neurotransmitters, 5-methyltetrahydrofolate, pyridoxyl 5-phosphate, and alpha-aminoadipic semialdehyde.

Her electrographic and clinical seizure continued to increase until her video EEG captured up to 20 brief seizures per hour. She was given fosphenytoin 20 mg/kg IV x1 with resolution of seizure activity. She was subsequently given pyridoxine 100 mg IV x1 and her EEG background activity become discontinuous and consistent with a burst suppression coma pattern for several hours before reverting to the previously described baseline. Seizures did not recur. She was discharged home 3 days later on keppra prophylaxis and vitamin B6 100 mg daily. A stat epilepsy panel was sent out prior to discharge.

Ten days after seizure onset, the infant’s CSF studies returned with a pyridoxyl 5-phosphate level of < 5 umol/L and an alpha-aminoadipic semialdehyde level of 6.89 umol/L (elevated); these findings are consistent with a diagnosis of pyridoxine responsive epilepsy. She was subsequently weaned off of levetiracetam and continues on pyridoxine 35 mg/kg/day with excellent seizure control. Her genetic testing returned with 2 pathogenic variants of ALDH7A1 further supporting the diagnosis of pyridoxine responsive epilepsy.

Pyridoxine responsive epilepsy is an organic aciduria associated with intractable perinatal seizures that respond exquisitely to large doses of vitamin B6; the most common cause is a deficiency in the protein antiquitin (ATQ) encoded by the ALDH7A1 gene.

Infant’s typically present within the first week of life with intractable seizures without a history of perinatal distress or concerns for hypoxic ischemic injuries. However, the response of seizures to initial administration of antiepileptic medications can mimic the course of hypoxic injuries and mislead clinicians. A trial of intravenous pyridoxine may lead to abrupt seizure cessation, but does not necessarily do so. Intravenous pyridoxine can also lead to apnea in this patient population and should be undertaken in an intensive care setting. The EEG record can briefly convert to a burst suppression pattern before reverting to baseline. Lifelong pyridoxine supplementation is required for seizure control, but most patients will still develop a variable degree of intellectual disability.

Laura C. Speltz, MD, is assistant professor of neurology at the University of Minnesota School of Medicine, and a pediatric neurologist at University of Minnesota Masonic Children’s Hospital. 

1. Stockler S, Plecko B, Gospe SM, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. 

2011;104(1-2):48-60. doi: 10.1016/j.ymgme.2011.05.014.

A newborn presents with new onset episodes of lateral gaze deviation with extremity stiffening.

Laura C. Speltz, MD

Articles

Cyclic Vomiting, Incontinence in a Young Boy

Case Report: New Onset Paroxysmal Episodes in an Infant